Recombinant human nerve growth factor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human nerve growth factor, covering 2021-11-04 to 2021-11-04. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy [Phase 2]